GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 77 filers reported holding GLYCOMIMETICS INC in Q3 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $578,000 | -91.9% | 253,516 | -81.1% | 0.02% | -90.6% |
| Q4 2019 | $7,109,000 | -17.4% | 1,343,845 | -32.7% | 0.17% | -41.0% |
| Q3 2019 | $8,610,000 | -64.0% | 1,997,647 | -0.5% | 0.29% | -57.5% |
| Q2 2019 | $23,941,000 | -4.8% | 2,008,447 | -0.5% | 0.68% | -8.0% |
| Q1 2019 | $25,147,000 | +34.2% | 2,018,247 | +2.0% | 0.74% | -2.4% |
| Q4 2018 | $18,737,000 | -36.5% | 1,978,547 | -3.4% | 0.75% | -16.9% |
| Q3 2018 | $29,493,000 | -9.9% | 2,048,147 | +0.9% | 0.91% | -18.4% |
| Q2 2018 | $32,733,000 | -11.6% | 2,029,347 | -11.1% | 1.11% | -22.2% |
| Q1 2018 | $37,041,000 | +14.3% | 2,282,268 | +18.2% | 1.43% | +1.5% |
| Q4 2017 | $32,416,000 | +90.9% | 1,930,668 | +59.0% | 1.41% | +68.1% |
| Q3 2017 | $16,985,000 | +153.8% | 1,214,088 | +102.5% | 0.84% | +105.9% |
| Q2 2017 | $6,692,000 | – | 599,620 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,000,000 | $5,220,000 | 0.73% |
| NEA Management Company, LLC | 4,764,440 | $8,290,126 | 0.63% |
| Artal Group S.A. | 8,589,064 | $14,945 | 0.46% |
| BVF INC/IL | 9,544,262 | $16,607,016 | 0.46% |
| Sargent Investment Group, LLC | 108,000 | $187,920 | 0.05% |
| Intellectus Partners, LLC | 73,475 | $127,847 | 0.04% |
| XTX Topco Ltd | 29,998 | $52,197 | 0.01% |
| AXA S.A. | 1,631,509 | $2,838,826 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,149,656 | $1,999 | 0.01% |
| TOBIAS FINANCIAL ADVISORS, INC. | 15,000 | $26,100 | 0.01% |